Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 1
2006 1
2009 3
2010 2
2011 5
2012 9
2013 10
2014 15
2015 8
2016 10
2017 8
2018 12
2019 10
2020 11
2021 6
2022 5
2023 7
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

111 results

Results by year

Filters applied: . Clear all
Page 1
Alpelisib for PIK3CA-Mutated, Hormone Receptor-Positive Advanced Breast Cancer.
André F, Ciruelos E, Rubovszky G, Campone M, Loibl S, Rugo HS, Iwata H, Conte P, Mayer IA, Kaufman B, Yamashita T, Lu YS, Inoue K, Takahashi M, Pápai Z, Longin AS, Mills D, Wilke C, Hirawat S, Juric D; SOLAR-1 Study Group. André F, et al. N Engl J Med. 2019 May 16;380(20):1929-1940. doi: 10.1056/NEJMoa1813904. N Engl J Med. 2019. PMID: 31091374 Clinical Trial.
Focus on lung cancer screening.
Tartarone A, Lerose R, Aieta M. Tartarone A, et al. Among authors: aieta m. J Thorac Dis. 2020 Jul;12(7):3815-3820. doi: 10.21037/jtd.2020.02.17. J Thorac Dis. 2020. PMID: 32802463 Free PMC article. Review.
INOVATYON/ ENGOT-ov5 study: Randomized phase III international study comparing trabectedin/pegylated liposomal doxorubicin (PLD) followed by platinum at progression vs carboplatin/PLD in patients with recurrent ovarian cancer progressing within 6-12 months after last platinum line.
Colombo N, Gadducci A, Sehouli J, Rulli E, Mäenpää J, Sessa C, Montes A, Ottevanger NB, Berger R, Vergote I, D'Incalci M, Churruca Galaz C, Chekerov R, Nyvang GB, Riniker S, Herbertson R, Fossati R, Barretina-Ginesta MP, Deryal M, Mirza MR, Biagioli E, Iglesias M, Funari G, Romeo M, Tasca G, Pardo B, Tognon G, Rubio-Pérez MJ, DeCensi A, De Giorgi U, Zola P, Benedetti Panici P, Aglietta M, Arcangeli V, Zamagni C, Bologna A, Westermann A, Heinzelmann-Schwarz V, Tsibulak I, Wimberger P, Poveda A; INOVATYON study group. Colombo N, et al. Br J Cancer. 2023 Apr;128(8):1503-1513. doi: 10.1038/s41416-022-02108-7. Epub 2023 Feb 9. Br J Cancer. 2023. PMID: 36759720 Free PMC article. Clinical Trial.
Nine-Week Versus One-Year Trastuzumab for Early Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer: 10-Year Update of the ShortHER Phase III Randomized Trial.
Conte P, Bisagni G, Piacentini F, Sarti S, Minichillo S, Anselmi E, Aieta M, Gebbia V, Schirone A, Musolino A, Garrone O, Beano A, Rimanti A, Giotta F, Turletti A, Miglietta F, Dieci MV, Vicini R, Balduzzi S, D'Amico R, Guarneri V. Conte P, et al. Among authors: aieta m. J Clin Oncol. 2023 Nov 10;41(32):4976-4981. doi: 10.1200/JCO.23.00790. Epub 2023 Sep 25. J Clin Oncol. 2023. PMID: 37748109 Free PMC article. Clinical Trial.
Lenvatinib for the treatment of renal cell carcinoma.
Roviello G, Corona SP, Bozza G, Aieta M, Generali D, Rodriquenz MG, Mileo AM, Imperatori M, Ianza A, Conca R, Sobhani N. Roviello G, et al. Among authors: aieta m. Expert Opin Investig Drugs. 2018 May;27(5):507-512. doi: 10.1080/13543784.2018.1472235. Epub 2018 May 14. Expert Opin Investig Drugs. 2018. PMID: 29718721 Free article. Review.
The evolving landscape in advanced penile cancer.
Buonerba C, Di Lorenzo G, Calderoni G, Ferro M, Perri F, Lombardi L, Ardito R, Federico P, Placido S, Aieta M. Buonerba C, et al. Among authors: aieta m. Future Sci OA. 2015 Nov 1;1(3):FSO9. doi: 10.4155/fso.15.7. eCollection 2015 Nov. Future Sci OA. 2015. PMID: 28031884 Free PMC article. No abstract available.
Circulating tumor cells: utopia or reality?
Conteduca V, Zamarchi R, Rossi E, Condelli V, Troiani L, Aieta M. Conteduca V, et al. Among authors: aieta m. Future Oncol. 2013 Sep;9(9):1337-52. doi: 10.2217/fon.13.101. Future Oncol. 2013. PMID: 23980681 Review.
Somatostatin Analog Therapy in Small Cell Lung Cancer.
Tartarone A, Lerose R, Aieta M. Tartarone A, et al. Among authors: aieta m. Semin Nucl Med. 2016 May;46(3):239-42. doi: 10.1053/j.semnuclmed.2015.12.004. Semin Nucl Med. 2016. PMID: 27067504 Review.
111 results